Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | TGM2 | P21980 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KLK1 | P06870 | 1/20 | 0.38 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7198930 | 0.84 | TERT (0.49) | FPR2TBXAS1MAPK1ALDH1A1TSHR | |
| SCHEMBL435392 | 0.81 | TBXAS1 (0.50) | TBXAS1GAATERT | |
| SCHEMBL5630310 | 0.81 | FPR2 (0.54) | FPR2TAAR1TBXAS1MAPK1KLK1 | |
| SCHEMBL27993527 | 0.80 | TBXAS1 (0.52) | TGM2TBXAS1GAATERT | |
| SCHEMBL6451096 | 0.79 | FPR2 (0.55) | FPR2TAAR1TBXAS1MAPK1KLK1 | |
| SCHEMBL4141453 | 0.78 | FPR2 (0.51) | FPR2TAAR1TBXAS1MAPK1KLK1 | |
| SCHEMBL5630316 | 0.77 | FPR2 (0.54) | FPR2TAAR1TBXAS1MAPK1KLK1 | |
| SCHEMBL14612333 | 0.77 | FPR2 (0.54) | FPR2TAAR1TBXAS1MAPK1KLK1 | |
| SCHEMBL1258259 | 0.77 | FPR2 (0.54) | FPR2TAAR1TBXAS1MAPK1KLK1 | |
| SCHEMBL6029787 | 0.75 | FPR2 (0.51) | FPR2TAAR1TBXAS1MAPK1KLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328547-B1 | COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS | BASF SE (DE) | 2014-03-05 | — | — | EP | claimed |
| EP-2039343-B1 | Cosmetic compositions containing a cationic copolymer and a particular amino silicone and uses thereof | OREAL (FR) | 2012-12-05 | — | — | EP | claimed |
| EP-2072084-A2 | Cosmetic compositions containing a cationic copolymer, an amino silicone and a cationic polymer, and uses thereof | L'Oréal (FR) | 2009-06-24 | — | — | EP | claimed |
| US-20090130038-A1 | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE ESTER OF A C8-C24 FATTY ACID AND OXYETHYLENATED SORBITAN COMPRISING 2 TO 10 OXYETHYLENE MOTIFS, AND COSMETIC TREATMENT METHODS EMPLOYING SAID COMPOSITIONS | L'OREAL S.A. (FR) | 2009-05-21 | — | — | US | claimed |
| EP-2039344-A2 | Cosmetic composition comprising a cationic copolymer and an anionic associative polymer and cosmetic treatment process | L'Oréal (FR) | 2009-03-25 | — | — | EP | claimed |
| EP-2039345-A1 | Cosmetic compositions containing a cationic copolymer and a particular triglyceride and uses thereof | L'Oréal (FR) | 2009-03-25 | — | — | EP | claimed |
| EP-2039346-A1 | Cosmetic composition comprising a cationic copolymer and a starch and cosmetic treatment process | L'Oréal (FR) | 2009-03-25 | — | — | EP | claimed |
| EP-2039343-A1 | Cosmetic compositions containing a cationic copolymer and a particular amino silicone and uses thereof | L'Oréal (FR) | 2009-03-25 | — | — | EP | claimed |
| US-20090074696-A1 | COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER AND A STARCH AND COSMETIC TREATMENT PROCESS THEREOF | L'OREAL S.A. (FR) | 2009-03-19 | — | — | US | claimed |
| EP-2036590-A2 | Cosmetic compositions containing a cationic copolymer, a cyclodextrin and a surfactant, and uses thereof | L'Oréal (FR) | 2009-03-18 | — | — | EP | claimed |
| EP-0707077-B1 | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same | ORTHO CLINICAL DIAGNOSTICS INC (US) | 2004-11-17 | — | — | EP | claimed |
| EP-0702006-B1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLIN DIAG (US) | 2000-05-10 | — | — | EP | claimed |
| US-5582988-A | PRECIPITAION OF NUCLEIC ACID AND CATION POLYMER AT ACIDIC PH; ADJUSTMENT OF PH TO RELEASE NUCLEIC ACID | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-12-10 | — | — | US | claimed |
| US-5523368-A | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-06-04 | — | — | US | claimed |
| EP-0707077-A2 | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0702006-A1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-03-20 | — | — | EP | claimed |
| US-8846017-B2 | Cosmetic compositions comprising at least one cationic copolymer and at least one amino silicone and methods of use thereof | L'OREAL (FR) | 2014-09-30 | — | — | US | disclosed |
| EP-2039343-B1 | Cosmetic compositions containing a cationic copolymer and a particular amino silicone and uses thereof | OREAL (FR) | 2012-12-05 | — | — | EP | disclosed |
| EP-0702006-A1 | Weakly basic polymerizable monomers and polymers prepared therefrom | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-03-20 | — | — | EP | disclosed |
| US-5434270-A | Weakly basic polymerizable monomers and polymers prepared therefrom | EASTMAN KODAK COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074696-A1 | COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER AND A STARCH AND COSMETIC TREATMENT PROCESS THEREOF | TYR, OXGR1, OGFOD1 | FPR2 2096/4885TAAR1 432/4885TGM2 1548/4885 |
| US-20090130038-A1 | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE ESTER OF A C8-C24 FATTY ACID AND OXYETHYLENATED SORBITAN COMPRISING 2 TO 10 OXYETHYLENE MOTIFS, AND COSMETIC TREATMENT METHODS EMPLOYING SAID COMPOSITIONS | FABP4, FFAR4, ANXA4 | FPR2 550/4885TAAR1 2042/4885TGM2 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.